Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:alsoKnownAs |
gptkb:Remdesivir
|
| gptkbp:approvedBy |
gptkb:FDA
2020 |
| gptkbp:ATCCode |
J05AB16
|
| gptkbp:CASNumber |
1809249-37-3
|
| gptkbp:chemicalFormula |
C27H35N6O8P
|
| gptkbp:developedBy |
gptkb:Gilead_Sciences
|
| https://www.w3.org/2000/01/rdf-schema#label |
GS-5734
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
RNA polymerase inhibitor
|
| gptkbp:molecularWeight |
602.6 g/mol
|
| gptkbp:prodrugOf |
gptkb:GS-441524
|
| gptkbp:PubChem_CID |
121304016
DB14761 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
elevated liver enzymes allergic reactions |
| gptkbp:UNII |
O3P9A4EE1Z
|
| gptkbp:usedFor |
gptkb:COVID-19
gptkb:Ebola_virus_disease |
| gptkbp:bfsParent |
gptkb:remdesivir
|
| gptkbp:bfsLayer |
5
|